Drug-versus-Drug Adverse Event Rate Comparisons
- 1 January 2009
- journal article
- research article
- Published by Springer Nature in Drug Safety
- Vol. 32 (2), 137-146
- https://doi.org/10.2165/00002018-200932020-00006
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- ???Extreme Duplication??? in the US FDA Adverse Events Reporting System DatabaseDrug Safety, 2007
- Outpatient Gatifloxacin Therapy and Dysglycemia in Older AdultsNew England Journal of Medicine, 2006
- Statin Safety: A Systematic ReviewThe American Journal of Cardiology, 2006
- Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysisBMJ, 2005
- Glucose Homeostasis Abnormalities Associated with Use of GatifloxacinClinical Infectious Diseases, 2005
- Perspectives on the Use of Data Mining in PharmacovigilanceDrug Safety, 2005
- Atovaquone-Proguanil versus Chloroquine-Proguanil for Malaria Prophylaxis in Nonimmune Pediatric Travelers: Results of an International, Randomized, Open-Label StudyClinical Infectious Diseases, 2004
- Replication of the Weber Effect Using Postmarketing Adverse Event Reports Voluntarily Submitted to the United States Food and Drug AdministrationPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2004
- Ketorolac, diclofenac, and ketoprofen are equally safe for pain relief after major surgeryBritish Journal of Anaesthesia, 2002
- A Coefficient of Agreement for Nominal ScalesEducational and Psychological Measurement, 1960